Stemina uses metabolomic analysis of stem cells for the discovery of biomarkers for make use of in medication screening and drug development. Agilent also is offering Mass Profiler Professional software to help Stemina researchers interpret the complex data produced by metabolomics experiments. Related StoriesNew generation of RNAscope items for RNA-biomarker analysis in FFPE cells releasedOJ Bio at Medica 2015 – Point of Treatment diagnostics' role in reducing antibiotics prescribingResearchers introduce free iOS app to learn about autism in small children We are pleased to broaden our relationship with Agilent to progress our scientific platform and our discovery of important small molecules involved in developmental toxicity and autism, stated Beth Donley, Stemina CEO..

Aetna supports mHealth diabetes initiative in India Aetna , a leading global diversified healthcare benefits company, announced that it’s participating in a diabetes prevention plan in India led by nonprofit Arogya World that strives to attain one million customers via mobile text messages. This mobile health initiative, which has been backed by a consortium of organisations, aims to raise awareness about diabetes and its prevention through texts in 12 languages over two years. Diabetes is on the rise all over the world, including India where one survey estimates that some 40 million Indians already are diabetic. That true number is likely to reach 73.5 million by 2025, said Sandip Patel, head of Aetna International. We want to help people all over the world live healthier lives.